Source:http://linkedlifedata.com/resource/lhgdn/association:55111
| Subject | Predicate | Object | Context |
|---|---|---|---|
| lhgdn:association:55111 | lhgdn:found_in | pubmed-article:18398952 | lld:lhgdn |
| lhgdn:association:55111 | lhgdn:geneRifSource | Lack of the NAT2*4 haplotype is strongly linked to adverse effects with sulfosalazine therapy in Japanese patients with rheumatoid arthritis. | lld:lhgdn |
| lhgdn:association:55111 | lhgdn:mesh_code | D001172 | lld:lhgdn |
| lhgdn:association:55111 | lhgdn:associationIdType | http://http://linkedlifedat... | lld:lhgdn |
| lhgdn:association:55111 | lhgdn:umls_code | umls-concept:C0003873 | lld:mappings |
| entrez-gene:10 | lhgdn:associationId | lhgdn:association:55111 | lld:lhgdn |